Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H15F6N3O3S |
Molecular Weight | 479.396 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)C1=CC=CN=C1N2CCC(=CC2)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C(F)(F)F
InChI
InChIKey=SDUAWRFBHRAFBM-UHFFFAOYSA-N
InChI=1S/C19H15F6N3O3S/c20-18(21,22)15-2-1-9-26-16(15)28-10-7-12(8-11-28)17(29)27-13-3-5-14(6-4-13)32(30,31)19(23,24)25/h1-7,9H,8,10-11H2,(H,27,29)
Molecular Formula | C19H15F6N3O3S |
Molecular Weight | 479.396 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16971522
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16971522
A-784168 is a potent and selective antagonist of Vanilloid receptor type 1 (TRPV1). A-784168 has a good CNS penetration. Significant CNS penetration is necessary for a TRPV1 antagonist to produce broad-spectrum analgesia that was shown on animal models after oral administration of this compound.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16971522
Curator's Comment: Known to be CNS penetrant in rats. Human data not available
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4794 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16971522 |
25.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16971522 |
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16971522
rats: For oral administration, A-784168 in 10% dehydrated ethanol, 20% polysorbate 80, and 70% polyethylene glycol 400 (PEG) was administered 1 h before testing using a volume of 2 ml/kg. For intrathecal administration, compound was dissolved in 10% di-methyl-sulfoxide/90% hydroxyl-β-cyclodextrin, injected in a volume of 10 μl, and followed by a 10 μl saline flush
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16971522
A-784168 was identified as TRPV1 antagonists in a capsaicin-induced calcium flux assay using a fluorometric imaging plate reader. Concentration-effect curves for capsaicin-induced, increased intracellular Ca2+ in the presence of increasing concentrations of A-784168 (0-200 nM). A-784168 potently and competitively inhibited capsaicin-induced calcium flux into 1321N1 astrocytoma cells expressing recombinant human TRPV1. The IC50 value for inhibiting TRPV1 activation by 50 nM capsaicin was 25.0 nM. A-784168 inhibited pH 5.5-induced activation of recombinant TRPV1 expressed in HEK293 cells with similar potency IC50 = 14.0 ± 2.3 as well as activation by 3 μM NADA (IC50 = 33.7 ± 9.6) and 10 μM anandamide (IC50 = 35.1 ± 10.6). It also blocked 1 μM capsaicin-induced currents in rat dorsal root ganglion neurons using electrophysiologic methods (IC50 = 10 nM)
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:04:30 GMT 2023
by
admin
on
Sat Dec 16 10:04:30 GMT 2023
|
Record UNII |
LB160J37HD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
11420211
Created by
admin on Sat Dec 16 10:04:30 GMT 2023 , Edited by admin on Sat Dec 16 10:04:30 GMT 2023
|
PRIMARY | |||
|
824982-41-4
Created by
admin on Sat Dec 16 10:04:30 GMT 2023 , Edited by admin on Sat Dec 16 10:04:30 GMT 2023
|
PRIMARY | |||
|
LB160J37HD
Created by
admin on Sat Dec 16 10:04:30 GMT 2023 , Edited by admin on Sat Dec 16 10:04:30 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |